Studies on the protective effect of azepexole on ouabain-induced cardiac arrhythmias and lethality in guinea-pig

European Journal of Pharmacology
G P Thomas

Abstract

Azepexole, an alpha 2-adrenoceptor agonist (125, 250 and 500 micrograms/kg i.v.), was examined for its effect on ouabain-induced ventricular premature beats, ventricular tachyarrhythmias and lethality in guinea-pigs. The doses of ouabain required to cause ventricular arrhythmias and lethality were significantly higher in azepexole-treated animals. However, it did not offer any protection in reserpinised guinea-pigs. Idazoxan, the alpha 2-adrenoceptor antagonist (100 micrograms/kg i.v.) inhibited the protective action of azepexole while corynanthine, the alpha 1-adrenoceptor antagonist (1 mg/kg i.v.), potentiated the effect. Azepexole inhibited the rate of the ouabain-induced rise in mean arterial blood pressure and the peak pressor response. In isolated paced left atria of guinea-pig, azepexole (2.76 x 10(-3) M) did not offer any protection against extrasystolic contractions induced by ouabain. Therefore the protective effect of azepexole may be mediated through the stimulation of alpha 2-adrenoceptors and the resultant suppression of the indirect neural components of ouabain toxicity.

References

May 1, 1977·Progress in Cardiovascular Diseases·G R Ferrier
May 19, 1977·The New England Journal of Medicine
Apr 1, 1975·European Journal of Pharmacology·P R Saxena, K P Bhargava
Oct 1, 1988·British Journal of Pharmacology·S Al-DamlujiG M Besser
Mar 1, 1970·European Journal of Pharmacology·F R Ciofalo, G Treece
Dec 1, 1974·Japanese Journal of Pharmacology·H SaitoT Tanabe
Jun 1, 1969·British Journal of Pharmacology·A N DohadwallaE M Vaughan Williams
Nov 21, 1980·European Journal of Pharmacology·S P SivamS C Manchanda
Jan 1, 1983·Psychopharmacology·M J DeniardF V DeFeudis
Jul 1, 1984·Progress in Cardiovascular Diseases·T W SmithJ D Marsh
Nov 1, 1982·Naunyn-Schmiedeberg's Archives of Pharmacology·N E AndénU Thornström
May 1, 1984·Progress in Cardiovascular Diseases·T W SmithJ D Marsh
Dec 1, 1963·British Journal of Pharmacology and Chemotherapy·A SEKIYA, E M VAUGHANWILLIAMS

❮ Previous
Next ❯

Citations

Jan 13, 2010·Toxicology in Vitro : an International Journal Published in Association with BIBRA·Jian-Yong Qian, Liang Guo
Mar 11, 2005·Autonomic & Autacoid Pharmacology·A T Demiryürek, S Demiryürek

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.